Published online 13 March 2009
Haematologica, Vol 94, Issue 5, 693-699 doi:10.3324/haematol.2008.003020
Copyright © 2009 by Ferrata Storti Foundation
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (1)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bezemer, I. D.
Right arrow Articles by Bare, L. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bezemer, I. D.
Right arrow Articles by Bare, L. A.
Related Collections
Right arrowRelated Article

Thrombosis

F9 Malmö, factor IX and deep vein thrombosis

Irene D. Bezemer1, Andre R. Arellano2, Carmen H. Tong2, Charles M. Rowland2, Helen A. Ireland3, Kenneth A. Bauer4, Joseph Catanese2, Pieter H. Reitsma5,6, Carine J.M. Doggen1, James J. Devlin2, Frits R. Rosendaal1,5,3, Lance A. Bare2

1 Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, The Netherlands
2 Celera, Alameda, CA, USA
3 Department of Cardiovascular Genetics, Division of Medicine, University College London, London, UK
4 Beth Israel Deaconess Medical Center, Molecular Medicine Unit, Boston, MA, USA
5 Department of Thrombosis and Haemostasis, Leiden University Medical Center, Leiden, The Netherlands
6 Einthoven Laboratory for Experimental Vascular Medicine, Leiden University Medical Center, Leiden, the Netherlands

Correspondence: Frits R. Rosendaal, Department of Clinical Epidemiology, C7-P Leiden University Medical Center P.O. Box 9600 2300 RC Leiden, The Netherlands. E-mail:f.r.rosendaal{at}lumc.nl

Background: We recently reported the association between the Malmö sequence variant in F9 (rs6048) and deep vein thrombosis.

Design and Methods: We aimed to study whether the association between F9 Malmö and deep vein thrombosis is explained by linkage disequilibrium with nearby single-nucleotide polymorphisms, and whether the association is explained biologically by F9 Malmö affecting factor IX antigen levels or activation of factor IX. We investigated the association of F9 Malmö and 28 nearby single-nucleotide polymorphisms with deep vein thrombosis in men from two case-control studies, LETS (n=380) and MEGA (n=1,469). We assessed the association of F9 Malmö with factor IX antigen level in male control subjects from LETS (n=191) and two subsets of MEGA (n=823 and n=484) and the association with endogenous thrombin potential in LETS control men. We studied the association between F9 Malmö and factor IX activation peptide in 1,199 healthy middle-aged men from the NPHS-II cohort.

Results: In the combined LETS and MEGA studies, the odds ratio (95% confidence interval) for the G allele of F9 Malmö, compared with the A allele, was 0.80 (0.69–0.93). One single-nucleotide polymorphism in F9, rs422187, was strongly linked to F9 Malmö (r2=0.94) and was similarly associated with deep vein thrombosis. No other single-nucleotide polymorphism or haplotype tested was more strongly associated. Factor IX antigen level, factor IX activation peptide levels and endogenous thrombin potential did not differ between F9 Malmö genotypes.

Conclusions: The F9 Malmö sequence variant was the most strongly associated with deep vein thrombosis among common single-nucleotide polymorphisms in the region. However, the biological mechanism by which F9 Malmö affects risk remains unknown.

Key words: factor IX, single nucleotide polymorphism, venous thrombosis.


Related Article

Factor IX and deep vein thrombosis
Gordon Lowe
Haematologica 2009 94: 615-617. [Full Text] [PDF]



This article has been cited by other articles:


Home page
 JAMAHome page
I. D. Bezemer, L. A. Bare, A. R. Arellano, P. H. Reitsma, and F. R. Rosendaal
Updated Analysis of Gene Variants Associated With Deep Vein Thrombosis
JAMA, February 3, 2010; 303(5): 421 - 422.
[Full Text] [PDF]

Home page
 NEJMHome page
P. Simioni, D. Tormene, G. Tognin, S. Gavasso, C. Bulato, N. P. Iacobelli, J. D. Finn, L. Spiezia, C. Radu, and V. R. Arruda
X-Linked Thrombophilia with a Mutant Factor IX (Factor IX Padua)
N. Engl. J. Med., October 22, 2009; 361(17): 1671 - 1675.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
C. J. M. Doggen
High coagulant factors & venous thrombosis
Blood, October 1, 2009; 114(14): 2854 - 2855.
[Full Text] [PDF]

Home page
 haematolHome page
G. Lowe
Factor IX and deep vein thrombosis
Haematologica, May 1, 2009; 94(5): 615 - 617.
[Full Text] [PDF]